REDACTED Certain identified information, indicated by [*****], has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed. DATED: 15 February 2019 FRAMEWORK PARTNERING...Framework Partnering Agreement • July 24th, 2020 • CureVac B.V. • Pharmaceutical preparations • England and Wales
TABLE OF CONTENTFramework Partnering Agreement • November 2nd, 2023
REDACTED Certain identified information, indicated by [*****], has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm if publicly disclosed.Framework Partnering Agreement • January 25th, 2021 • CureVac N.V. • Pharmaceutical preparations
THIS AMENDMENT NUMBER 1 is made by and between Partner and CEPI, either of which may be referred to individually as a "Party" and together as the "Parties."
FRAMEWORK PARTNERING AGREEMENTFramework Partnering Agreement • May 18th, 2020
anticipated work phases are: [Pre-clinical Work Phase, First in Man, Phase I Work Phase, Phase II Work Phase, Pivotal Trial Work Phase and Stockpiling Work Phase].
